Thursday, April 18, 2024 11:46:32 AM
If he was doing the books, but now isn't, I for one would prefer Mark not take that on himself. So, you can scoff at bringing someone in to help on that, but I'm glad Mark is doing so.
To summarize, the tweet refers to 2 different people -- the CPA doing MIKP's books and the CPA who is MIKP's auditor (Barton). Probably this bookkeeping work is being farmed out to someone who is at most a part-time employee or perhaps a contractor or so. If DiPrima was doing this and now someone else is, no 8-k is needed over who is handling the books. But I agree that if and when DiPrima leaves MIKP's management team, then an 8-k is needed.
As for why Mark is late, I think it is safe to say that Mark's strength is coming up with amazing IP -- not with filing forms and navigating bureaucracy. I do think he is getting better at it, but the whole FINRA/reorg/split/SEC bureaucratic challenge is a lot. If I could be buying 0.0002s, I would.
I am obviously NOT an investment advisor.
Recent MIKP News
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 11/28/2023 10:00:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/22/2023 06:06:28 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 07:00:35 PM
- Form PREM14C - Preliminary information statements relating to merger or acquisition • Edgar (US Regulatory) • 11/02/2023 04:01:43 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 10/04/2023 04:01:33 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 08/23/2023 08:54:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/22/2023 06:10:15 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 01:07:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/28/2023 01:43:32 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM